Literature DB >> 30590060

Acute administration of ketamine attenuates the impairment of social behaviors induced by social defeat stress exposure as juveniles via activation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Sho Hasegawa1, Akira Yoshimi1, Akihiro Mouri2, Yoji Uchida1, Hirotake Hida3, Masayoshi Mishina4, Kiyofumi Yamada5, Norio Ozaki6, Toshitaka Nabeshima7, Yukihiro Noda8.   

Abstract

The impairment of social behaviors induced by social defeat stress exposure as juveniles is resistant to some antidepressants and an antipsychotic, although the underlying mechanisms and/or therapeutic target are not yet clear. In this study, we investigated the involvement of the glutamatergic neuronal system in the impairment of social behaviors in this model, as this system is known to be involved in many central pathologies. Acute administration of ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist and subsequent stimulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, attenuated the expression of impairment of social behaviors. Lack of the NMDA receptor GluN2A subunit or acute administration of ifenprodil, an NMDA receptor GluN2B subunit antagonist, did not cause an effect. There were no significant changes in NMDA function, as determined by the ratios of phosphorylated NMDA receptor subunits in the prefrontal cortex and hippocampus. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione, a selective AMPA receptor antagonist, prevented the effect of ketamine on the expression of impairment of social behaviors. On the contrary, the ratio of phosphorylated AMPA receptor GluA1 subunit in the hippocampus was significantly increased in the non-tested, defeated group. Ketamine increased the level of total protein, but not the ratio of phosphorylated GluA1 in the hippocampus of the non-tested, defeated group. In conclusion, exposure to social defeat stress as juveniles may induce the expression of impairment of social behaviors in adolescents via functional changes in GluA1. Activators of AMPA receptor signaling, such as ketamine, may constitute a novel treatment strategy for stress-related psychiatric disorders in adolescents with adverse juvenile experiences.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPA receptor; Juvenile; Ketamine; NMDA receptor; Social behaviors; Social defeat stress

Year:  2018        PMID: 30590060     DOI: 10.1016/j.neuropharm.2018.12.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  3 in total

1.  Enduring effects of adolescent ketamine exposure on cocaine- and sucrose-induced reward in male and female C57BL/6 mice.

Authors:  Israel Garcia-Carachure; Francisco J Flores-Ramirez; Samuel A Castillo; Anapaula Themann; Miguel A Arenivar; Joshua Preciado-Piña; Arturo R Zavala; Mary Kay Lobo; Sergio D Iñiguez
Journal:  Neuropsychopharmacology       Date:  2020-03-12       Impact factor: 7.853

2.  Redistribution of Monocarboxylate 1 and 4 in Hippocampus and Spatial Memory Impairment Induced by Long-term Ketamine Administration.

Authors:  Runtao Ding; Yaqing Tan; Ao Du; Gehua Wen; Xinghua Ren; Hui Yao; Weishu Ren; Huairu Liu; Xiaolong Wang; Hao Yu; Jun Yao; Baoman Li; Guohua Zhang; Yan Lu; Xu Wu
Journal:  Front Behav Neurosci       Date:  2020-04-17       Impact factor: 3.558

Review 3.  AMPA Receptor Function in Hypothalamic Synapses.

Authors:  Maria Royo; Beatriz Aznar Escolano; M Pilar Madrigal; Sandra Jurado
Journal:  Front Synaptic Neurosci       Date:  2022-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.